These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 177797

  • 1. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M, Takayanagi I, Ohkubo H, Takagi K.
    Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
    [No Abstract] [Full Text] [Related]

  • 2. On the mechanism of relaxation of tracheal muscle by theophylline and other cyclic nucleotide phosphodiesterase inhibitors.
    Fredholm BB, Brodin K, Strandberg K.
    Acta Pharmacol Toxicol (Copenh); 1979 Nov; 45(5):336-44. PubMed ID: 231892
    [Abstract] [Full Text] [Related]

  • 3. Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
    Murray KJ, England PJ.
    Biochem Soc Trans; 1992 May; 20(2):460-4. PubMed ID: 1327922
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of NZ-105, a 1,4-dihydropyridine derivative, on cyclic nucleotide phosphodiesterase activity.
    Yamashita T, Masuda Y, Sakai T, Tanaka S, Kasuya Y.
    J Pharm Pharmacol; 1993 Jun; 45(6):530-4. PubMed ID: 7689649
    [Abstract] [Full Text] [Related]

  • 6. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
    Levin RM, Weiss B.
    Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
    [No Abstract] [Full Text] [Related]

  • 7. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. I. A lack of correlation between inhibition of cyclic nucleotide phosphodiesterases and antigen-induced release of histamine from rat mast cells.
    Khandwala A, Van Inwegen R, Coutts S, Dally-Meade V, Jariwala N, Huang F, Musser J, Brown R, Loev B, Weinryb I.
    Int Arch Allergy Appl Immunol; 1984 Jul; 73(1):56-64. PubMed ID: 6198287
    [Abstract] [Full Text] [Related]

  • 8. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung.
    Fertel R, Weiss B.
    Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099
    [No Abstract] [Full Text] [Related]

  • 9. Antiphosphodiesterase activity and nonspecific smooth muscle relaxation tested on intestinal smooth muscles.
    Inatomi N, Takayanagi I, Takagi K.
    Jpn J Pharmacol; 1975 Feb; 25(1):63-9. PubMed ID: 168424
    [Abstract] [Full Text] [Related]

  • 10. Zinc-mediated inhibition of cyclic nucleotide phosphodiesterase activity and expression suppresses TNF-alpha and IL-1 beta production in monocytes by elevation of guanosine 3',5'-cyclic monophosphate.
    von Bülow V, Rink L, Haase H.
    J Immunol; 2005 Oct 01; 175(7):4697-705. PubMed ID: 16177117
    [Abstract] [Full Text] [Related]

  • 11. Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.
    Lugnier C, Schoeffter P, Le Bec A, Strouthou E, Stoclet JC.
    Biochem Pharmacol; 1986 May 15; 35(10):1743-51. PubMed ID: 2423089
    [Abstract] [Full Text] [Related]

  • 12. Influence of papaverine derivatives on phosphodiesterase activity, cyclic 3',5'-AMP levels and relaxing effect on rabbit ileum.
    Berndt SF, Schulz HU, Stock K.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Sep 15; 294(3):271-5. PubMed ID: 187961
    [Abstract] [Full Text] [Related]

  • 13. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE, Lugnier C.
    Br J Pharmacol; 1994 Oct 15; 113(2):445-50. PubMed ID: 7834194
    [Abstract] [Full Text] [Related]

  • 14. Accumulation of cAMP and positive inotropic effect evoked by isoproterenol under the graded inhibition of phosphodiesterase by papaverine in the isolated rabbit papillary muscle.
    Endoh M, Brodde OE, Schümann HJ.
    J Mol Cell Cardiol; 1975 Sep 15; 7(9):703-11. PubMed ID: 171423
    [No Abstract] [Full Text] [Related]

  • 15. Does sildenafil indirectly inhibit phosphodiesterase 3 in vascular smooth muscle?
    Maurice DH.
    Hypertension; 2003 Mar 15; 41(3):e2. PubMed ID: 12623968
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries.
    Birk S, Edvinsson L, Olesen J, Kruuse C.
    Eur J Pharmacol; 2004 Apr 05; 489(1-2):93-100. PubMed ID: 15063160
    [Abstract] [Full Text] [Related]

  • 17. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.
    Truss MC, Uckert S, Stief CG, Schulz-Knappe P, Hess R, Forssmann WG, Jonas U.
    Urology; 1995 May 05; 45(5):893-901. PubMed ID: 7747383
    [Abstract] [Full Text] [Related]

  • 18. Studies on the inhibition of phosphodiesterase-catalyzed cyclic AMP and cyclic GMP breakdown and relaxation of canine tracheal smooth muscle.
    Polson JB, Krzanowski JJ, Fitzpatrick DF, Szentivanyi A.
    Biochem Pharmacol; 1978 Jan 15; 27(2):254-6. PubMed ID: 203292
    [No Abstract] [Full Text] [Related]

  • 19. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
    Ahluwalia GS, Rhoads AR.
    Biochem Pharmacol; 1982 Mar 01; 31(5):665-9. PubMed ID: 6177320
    [Abstract] [Full Text] [Related]

  • 20. Actions of dibutyryl cyclic adenosine monophosphate, papaverine and isoprenaline on the intestinal smooth muscle.
    Takagi K, Takayanagi I, Tomiyama A.
    Jpn J Pharmacol; 1971 Aug 01; 21(4):477-83. PubMed ID: 4330225
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.